Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1678521Generated: October 31, 2026

4-Methylmorpholine → 2'-Chloro-5'-(3-cyclohexyl-ureido)-biphenyl-4-carboxylic acid {4-[4-(propane-1-sulfonyl)-piperazin-1-ylmethyl]-phenyl}-amide

https://huagongshe.com/reaction/1678521

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-MethylmorpholineHCID 7972—
ReactantMethanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 2733084—
Reactant4-[(4-(Propylsulfonyl)piperazin-1-yl)methyl]anilineHCID 28273548—
Reactant2'-Chloro-5'-(3-cyclohexyl-ureido)-biphenyl-4-carboxylic acidHCID 67373328—
SolventDimethylformamideHCID 6228—
Product2'-Chloro-5'-(3-cyclohexyl-ureido)-biphenyl-4-carboxylic acid {4-[4-(propane-1-sulfonyl)-piperazin-1-ylmethyl]-phenyl}-amideHCID 6737082114.5%

Reaction Steps

A mixture of 2′-Chloro-5′-(3-cyclohexyl-ureido)-biphenyl-4-carboxylic acid (150 mg), 4-(4-(propane-1-sulfonyl)-piperazin-1-ylmethyl)-phenylamine (236 mg) and HBTU (228 mg) in dry DMF (5 ml) containing N-methylmorpholine (0.13 ml) was stirred at room temp for 18 h. The mixture was then evaporated and the residue purified by chromatography. Gradient elution with 3%-20% 20DCM:8EtOH:1NH3 in DCM over 30 mins gave a white solid (38 mg)

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08008303B2
Source datasetuspto-grants-2011_08
ORD IDord-05497c3b64724012a4d16acb90c24e61
Source noteuspto-grants-2011_08